The program offers lower-cost, refurbished testing instruments as well as customer education, inventory management, and enhanced service agreements.

The company's laboratory-developed test (LDT) for neurofilament light chain (NfL) also gained New York State approval as part of the permitting process.

Financial and other terms of the deal were not disclosed.

The all-virtual program is currently looking for a second cohort of novel diagnostics technologies, with a Sept. 30 deadline for new applications.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...

According to a company executive, the transactions will provide QuidelOrtho with greater financial flexibility while funding its continued growth.

Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

NEW YORK – Agilent Technologies said Wednesday that it has received US Food and Drug Administration approval for a companion diagnostic test to inform the treatment of patients with mismatch repair ...

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

Last week, readers were most interested in a story about WHO's update to its operational handbook for diagnosing tuberculosis.